PDS Biotechnology (PDSB) Misses Q1 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.32), $0.10 worse than the analyst estimate of ($0.22).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• PDS Biotechnology Corp (PDSB) PT Lowered to $7 at H.C. Wainwright